SUGAR LAND--May 8, 2017--Reported by Annette Kreuger, Industrial Info Resources, Incorporated (Sugar Land, Texas)--Like any long-term union, the one shared between the U.S. Northeast Region, which comprises Delaware, New Jersey, New York and Pennsylvania, and the Life Science Industry is a classic example of a love/hate relationship. The Northeast Region has been pummeled over the past few years with scores of pharmaceutical plants closing and lucrative jobs lost, but continues to be an industry magnet for investment, with a hefty $7.05 billion in active life science projects.

Within this article: Details on some of the highest-valued active projects in the life science industry in the U.S. Northeast, including those from leading industry players like Regeneron Pharmaceuticals Incorporated (NASDAQ:REGN), Eurofins Lancaster Laboratories and Laboratorias HIPRA.